Literature DB >> 3401058

Response of rheumatoid arthritis to chemotherapy for Hodgkin's disease in a patient with IgA deficiency and overlap connective tissue disease.

M G Cohen1, B Janssen, J Webb.   

Abstract

A patient with IgA deficiency presented with classical rheumatoid arthritis (RA) and subsequently, features of multiple other connective tissue diseases (CTD). When Hodgkin's disease later developed the patient received combination chemotherapy, which induced remission of both neoplastic and connective tissue diseases. As the RA remained in remission for three years this case may offer insight into a mode of use of cytotoxic agents in CTD.

Entities:  

Mesh：

Year:  1988        PMID： 3401058      PMCID： PMC1003579          DOI： 10.1136/ard.47.7.603

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  2 in total

1.  Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Authors:  H A Austin; J H Klippel; J E Balow; N G le Riche; A D Steinberg; P H Plotz; J L Decker
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

2.  Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.

Authors:  M Csuka; G F Carrera; D J McCarty
Journal:  JAMA       Date:  1986-05-02       Impact factor: 56.272
  2 in total
  1 in total

1.  Lymphoma chemotherapy as remission inducing treatment in rheumatoid arthritis.

Authors:  P J Sheldon
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.